TY - JOUR AU - Leena Muppa, AU - Shilpa Mary Saimon, AU - Nidhi Susan Abraham, AU - Sachin Baby Thomas, AU - Anakha .S Sachu, AU - Ann Mary Alex, PY - 2021/03/21 Y2 - 2024/03/28 TI - Novel Corona Virus and acute ischemic stroke – An Over view JF - International Journal of Research in Pharmacology & Pharmacotherapeutics JA - Int. J. of Res. in Pharmacology &Pharmacotherapeutics VL - 10 IS - 1 SE - Articles DO - 10.61096/ijrpp.v10.iss1.2021.1-7 UR - https://ijrpp.com/ijrpp/article/view/3 SP - 1-7 AB - The COVID-19 pandemic represents an unprecedented global healthcare challenge. Aside from being a primary respiratory disease, acute ischemic stroke has emerged as a complication of the disease. There are many similarities in the risk factors for severe COVID-19 as well as ischemic stroke, which underscore the complex relationship between these two conditions. Acute ischemic stroke in patients with COVID-19 may be due to usual causes such as atherosclerosis, hypertension, and atrial fibrillation. Approximately 5% of hospitalized patients with covid -19 suffer from stroke with over 80% of them being ischemic stroke. Rapid assessment and time-sensitive interventions required for optimum outcomes in acute stroke care have been complicated by COVID-19. In this review, however, we focus on mechanisms of stroke that appear to be directly related to COVID-19, the clinical features of COVID-19 patients who develop ischemic stroke, and in addition we have discus the management approaches of acute ischemic stroke in COVID-19 patients. ER -